InsidersTradesSigma
Total declarations
Companies
▲ Purchases (24 ops.)
▼ Sales (15 ops.)
Insider track record
ExecutiveDisclosed buys
24
Disclosed sells
15
T+90 hit rate
27%
T+90 mean return
-27.3%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Fletcher Aaron G.L., Director. Director active across 8 companies, notably Lantern Pharma Inc.. Aggregated, 61 disclosures have been recorded. Breakdown: 24 buys · 15 sells. Total volume traded: €9.6m. History available since 4 April 2022. The latest transaction was disclosed on 19 September 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations61 total
25,000 sharesCommon StockSEC:0001789490-26-000002:0
7,729 shares@ US$0.840.7% of flowCommon StockSEC:0001104659-25-092671:0
71,428 shares@ US$7.0050.0% of flowCommon StockSEC:0001104659-25-063991
Ideal exit: 24 Mar 2026 (T+270)
71,428 shares@ US$7.000.68% mcap50.0% of flowCommon StockSEC:0001104659-25-063991:0
Ideal exit: 24 Mar 2026 (T+270)
7,206 shares@ US$3.0950.0% of flowCommon StockSEC:0001104659-25-059528
3 shares@ US$3.400.0% of flowCommon StockSEC:0001104659-25-059106
3 shares@ US$3.400.0000% mcap0.0% of flowCommon StockSEC:0001104659-25-059106:0
7,206 shares@ US$3.090.048% mcap50.0% of flowCommon StockSEC:0001104659-25-059528:0
5,314 shares@ US$8.004.3% of flowCommon StockSEC:0001104659-24-091371:0
884,427 sharesCommon StockSEC:0001104659-24-089822:0
8,500 shares0Common StockSEC:0001104659-24-070572:0
930 shares@ US$6.250.8% of flowCommon StockSEC:0001104659-24-065616:0
1,859 shares@ US$6.331.5% of flowCommon StockSEC:0001104659-24-065616:1
6,944 shares@ US$6.255.7% of flowCommon StockSEC:0001104659-24-065616:2
13,888 shares@ US$6.3311.5% of flowCommon StockSEC:0001104659-24-065616:3
2,126 shares@ US$6.251.7% of flowCommon StockSEC:0001104659-24-065616:4
4,253 shares@ US$6.333.5% of flowCommon StockSEC:0001104659-24-065616:5
4,649 shares@ US$4.402.7% of flowCommon StockSEC:0001104659-24-029534:0
7,347 shares@ US$3.133.0% of flowCommon StockSEC:0001104659-24-005242:0
53,640 shares@ US$3.4423.8% of flowCommon StockSEC:0001104659-23-122540:0
500,095 shares@ US$1.0564.3% of flowCommon StockSEC:0001104659-23-116868:0
77,953 sharesConvertible NotesSEC:0001104659-23-074424:0
6,000 shares0Common StockSEC:0001104659-23-070932:0
9,214 shares@ US$2.47883.1% of flowCommon StockSEC:0001104659-22-126432:0
Ideal exit: 8 Sept 2023 (T+270)
57,052 shares@ US$2.478819.1% of flowCommon StockSEC:0001104659-22-126432:1
Ideal exit: 8 Sept 2023 (T+270)
25 of 61 declarations
About Fletcher Aaron G.L.
Fletcher Aaron G.L. is a director at Lantern Pharma Inc.
